Skip to main content
Selvita S.A. logo

Selvita S.A. — Investor Relations & Filings

Ticker · SLV ISIN · PLSLVCR00029 LEI · 25940057WQ9YP5MOQF28 WAR Professional, scientific and technical activities
Open in API
Filings indexed 1,179 across all filing types
Latest filing 2021-02-08 Director's Dealing
Country PL Poland
Listing WAR SLV

About Selvita S.A.

https://selvita.com/

Selvita S.A. is a preclinical contract research organization (CRO) providing integrated services for the pharmaceutical and biotechnology sectors. The company offers comprehensive solutions across the drug discovery and development continuum, from target validation to preclinical candidate nomination. Core drug discovery capabilities include medicinal chemistry, pharmacology, DMPK, and protein sciences, supporting a wide range of modalities such as small molecules, antibodies, and protein degraders. For drug development, Selvita provides analytical support for small and large molecules, formulation, microbiology services, and manufacturing for clinical trials. The company operates under GMP and GLP quality standards, offering flexible engagement models that range from standalone studies to fully integrated programs.

Recent filings

Filing Released Lang Actions
Powiadomienie_art.19 MAR Selvita SA
Director's Dealing Classification · 100% confidence The document is titled "Powiadomienie o transakcji/transakcjach, o którym mowa w art. 19 ust. 1 Rozporządzenia MAR dla osób pełniących obowiązki zarządcze/osób blisko związanych z osobą pełniącą obowiązki zarządcze" (Notification of a transaction(s) referred to in Article 19(1) of the MAR Regulation for persons discharging managerial responsibilities/persons closely associated with such a person). This explicitly details a transaction (Zbycie - Disposal) involving shares by a person discharging managerial responsibilities (Piotr Romanowski, Chairman of the Supervisory Board). This perfectly matches the definition of Director's Dealing (insider trades). Matching Definition: 9. Director's Dealing (Code: DIRS): Report of personal share transactions by company directors and executives (insider trades).
2021-02-08 Polish
Powiadomienie od osoby pełniącej obowiązki zarządcze w Spółce – art. 19 MAR - Content (PL)
Director's Dealing Classification · 98% confidence The document text is very short (336 characters) and explicitly states that the management (Piotr Romanowski, Chairman of the Supervisory Board) has notified the company of a transaction based on Article 19(1) of the MAR Regulation. This type of notification concerns personal share transactions by executives or directors. The text also mentions that the content of the notification is attached ('Treść powiadomienia stanowi załącznik do niniejszego raportu'). Since this is a notification about insider trading/director dealing, the most specific category is 'Director's Dealing' (DIRS). Although it mentions an attachment, the core subject matter is the director's transaction, making DIRS more appropriate than the general RPA/RNS fallback.
2021-02-08 Polish
Terminy przekazywania raportów okresowych w 2021 roku / Publication dates for periodic reports in 2021 - Content (PL)
Report Publication Announcement Classification · 100% confidence The document text explicitly states that the Management Board is announcing the publication dates for periodic reports (annual, quarterly, semi-annual) for the year 2021. This is a formal announcement regarding the schedule of future financial reports, not the reports themselves. According to Rule 2 (The 'MENU VS MEAL' Rule), when a document announces the publication of reports, it should be classified as a Report Publication Announcement (RPA). The document is short (2680 characters) and serves this exact purpose.
2021-01-13 Polish
Otrzymanie kolejnych istotnych zleceń / Conclusion of significant work orders - Content (PL)
Regulatory Filings Classification · 99% confidence The document is a formal announcement by the Management Board of Selvita S.A. (Emitent) regarding the securing of new, significant purchase orders (contracts for services) from a client. It details the value, scope (chemical synthesis, drug discovery support), and expected execution period (2021). This type of announcement, detailing material business contracts or significant operational developments, is typically classified as a general regulatory filing or a specific business update. Since it is not a full financial report (10-K, IR), an earnings release (ER), a management discussion (MDA), or a capital event (CAP), it fits best under the general 'Regulatory Filings' (RNS) category, as it is a 'raport bieżący' (current report) informing the market of a material event. Given the context of Polish regulatory filings, 'RNS' serves as the appropriate catch-all for material, non-standardized disclosures.
2021-01-05 Polish
Zawarcie umowy nabycia przez Selvita S.A. 100% udziałów w Fidelta d.o.o. – Zamknięcie Transakcji - Content (EN)
M&A Activity Classification · 98% confidence The document text explicitly discusses the 'Closing of an acquisition' of one company (Fidelta) by another (Selvita S.A.), detailing the final agreement, purchase price, financing sources (own funds and bank loan), and its strategic importance relative to the issuer's Capital Group Strategy. This content directly relates to a significant corporate transaction involving mergers, acquisitions, or major strategic investments. This aligns best with the 'M&A Activity' category (TAR), which covers merger proposals or takeover bids, even if this is the closing announcement rather than the initial proposal. It is not a standard financial report (10-K, IR), an earnings release (ER), or a financing update (CAP), as it focuses on the completion of a specific acquisition.
2021-01-05 English
Zawarcie umowy nabycia przez Selvita S.A. 100% udziałów w Fidelta d.o.o. – Zamknięcie Transakcji - Content (PL)
M&A Activity Classification · 99% confidence The document text, written in Polish, describes the finalization of a significant corporate transaction: the acquisition of 100% of the shares of Fidelta by Selvita S.A. (the Issuer) from Galapagos NV for EUR 31.2 million. It references previous reports (37/2020 and 40/2020) and details the financing structure (equity and debt) and the strategic importance of the deal. This clearly indicates an announcement related to a merger or acquisition activity. Based on the provided definitions, the most appropriate code is 'TAR' (M&A Activity). The document is a substantive report detailing the transaction, not merely an announcement that a report is available (which would suggest RPA or RNS).
2021-01-05 Polish

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.